October

Allied respiratory professionals Cooper B.G., Troosters T., Burge G., Field D., Hrafnkelsdottir S.S., Pitta F., Lloyd J.K., Steenbuggen I. Eur Respir J 2010; 36: 701-703
The continuing challenge of air pollution Brunekreef B. Eur Respir J 2010; 36: 704-705
Tainted eponyms in medicine: the “Clara” cell joins the list Woywodt A., Lefrak S., Matteson E. Eur Respir J 2010; 36: 706-708
Rho kinase inhibitors for pulmonary hypertension: waiting for clinical evidence Pacaud P., Loirand G. Eur Respir J 2010; 36: 709-711
The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal Pletz M.W., Welte T., Klugman K.P. Eur Respir J 2010; 36: 712-713
The European Respiratory Journal targets tuberculosis Lange C., Yew W.W., Migliori G.B., Raviglione M. Eur Respir J 2010; 36: 714-715
Lung development, lung growth and the future of respiratory medicine Ranganathan S. Eur Respir J 2010; 36: 716-717
The light at the end of the tunnel: is COPD prevalence changing? Celli B.R. Eur Respir J 2010; 36: 718-719
What makes large epidemiological studies comparable? Cerveri I., De Marco R. Eur Respir J 2010; 36: 720-721
The Clara cell: a “Third Reich eponym”? Winkelmann A., Noack T. Eur Respir J 2010; 36: 722-727
Factors influencing duration of exposure with symptoms and costs of occupational asthma Miedinger D., Malo J-L., Ghezzo H., L'Archevêque J., Zunzunegui M-V. Eur Respir J 2010; 36: 728-734
Application of a prediction model for work-related sensitisation in bakery workers Meijer E., Suarthana E., Rooijackers J., Grobbee D.E., Jacobs J.H., Meijster T., de Monchy J.G.R., van Otterloo E., van Rooy F.G.B.G.J., Spithoven J.J.G., Zaat V.A.C., Heederik D.J.J. Eur Respir J 2010; 36: 735-742
The occupational contribution to severe exacerbation of asthma Henneberger P.K., Mirabelli M.C., Kogevinas M., Antó J.M., Plana E., Dahlman- Höglund A., Jarvis D.L., Kromhout H., Lillienberg L., Norbäck D., Olivieri M., Radon K., Torén K., Urrutia I., Villani S., Zock J.P. Eur Respir J 2010; 36: 743-750
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Malo de Molina R., Mortensen E.M., Restrepo M.I., Copeland L.A., Pugh M.J.V., Anzueto A. Eur Respir J 2010; 36: 751-757
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007 Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran-Tauleria E., Muñoz L., Jiménez-Ruiz C.A., Masa J.F., Viejo J.L., Villasante C., Fernández-Fau L., Sánchez G., Sobradillo-Peña V. Eur Respir J 2010; 36: 758-765
No increase in the prevalence of COPD in two decades Vasankari T.M., Impivaara O., Heliövaara M., Heistaro S., Liippo K., Puukka P., Saarelainen S., Kanervisto M., Jousilahti P. Eur Respir J 2010; 36: 766-773
Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial Keranis E., Makris D., Rodopoulou P., Martinou H., Papamakarios G., Daniil Z., Zintzaras E., Gourgoulianis K.I. Eur Respir J 2010; 36: 774-780
Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD Van Pottelberge G.R., Bracke K.R., Van den Broeck S., Reinartz S.M., van Drunen C.M., Wouters E.F., Verleden G.M., Vermassen F.E., Joos G.F., Brusselle G.G. Eur Respir J 2010; 36: 781-791
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study Ghofrani H.A., Hoeper M.M., Halank M., Meyer F.J., Staehler G., Behr J., Ewert R., Weimann G., Grimminger F. Eur Respir J 2010; 36: 792-799
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil Mouchaers K.T.B., Schalij I., de Boer M.A., Postmus P.E., van Hinsbergh V.W.M., van Nieuw Amerongen G.P., Vonk Noordegraaf A., van der Laarse W.J. Eur Respir J 2010; 36: 800-807
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension Dahal B.K., Kosanovic D., Pamarthi P.K., Sydykov A., Lai Y-J., Kast R., Schirok H., Stasch J-P., Ghofrani H.A., Weissmann N., Grimminger F., Seeger W., Schermuly R.T. Eur Respir J 2010; 36: 808-818
Elevated brain natriuretic peptide predicts mortality in interstitial lung disease Corte T.J., Wort S.J., Gatzoulis M.A., Engel R., Giannakoulas G., Macdonald P.M., Wells A.U. Eur Respir J 2010; 36: 819-825
The impact of a delay in intensive care unit admission for community-acquired pneumonia Phua J., Ngerng W.J., Lim T.K. Eur Respir J 2010; 36: 826-833
Influence of genetic ancestry on the risk of obstructive sleep apnoea syndrome Guindalini C., Colugnati F.A.B., Pellegrino R., Santos-Silva R., Bittencourt L.R.A., Tufik S. Eur Respir J 2010; 36: 834-841
Is tidal expiratory flow limitation predictive of sleep-related disorders in the elderly? Guillot M., Costes F., Sforza E., Maudoux D., Bertoletti L., Barthélémy J.C., Roche F. Eur Respir J 2010; 36: 842-848
Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing Bourjeily G., Raker C.A., Chalhoub M., Miller M.A. Eur Respir J 2010; 36: 849-855
Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., Mandomando I., Sigaúque B., Nhalungo D., Esquinas C., Quintó L., Alonso P.L., Torres A. Eur Respir J 2010; 36: 856-863
Characteristics of hospitalised patients with 2009 H1N1 influenza in Chile Riquelme R., Riquelme M., Rioseco M.L., Inzunza C., Gomez Y., Contreras C., Riquelme J., Peyrani P., Wiemken T., Ramirez J. Eur Respir J 2010; 36: 864-869
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Oxlade O., Schwartzman K., Pai M., Heymann J., Benedetti A., Royce S., Menzies D. Eur Respir J 2010; 36: 870-877
Ongoing tuberculosis transmission to children in Greenland Soborg B., Koch A., Thomsen V.Ø. , Ladefoged K., Andersson M., Wohlfahrt J., Melbye M., Andersen A.B. Eur Respir J 2010; 36: 878-884
Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer Kumar S., Guleria R., Singh V., Bharti A.C., Mohan A., Das B.C. Eur Respir J 2010; 36: 885-892
Systemic sclerosis and bilateral lung transplantation: a single centre experience Saggar R., Khanna D., Furst D.E., Belperio J.A., Park G.S., Weigt S.S., Kubak B., Ardehali A., Derhovanessian A., Clements P.J., Shapiro S., Hunter C., Gregson A., Fishbein M.C., Lynch III J.P., Ross D.J., Saggar R. Eur Respir J 2010; 36: 893-900
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Martínez-Olondris P., Sibila O., C. Agustí, Rigol M., Soy D., Esquinas C., Piñer R., Luque N., Guerrero L., Quera M.Á., Marco F., de la Bellacasa J.P., Ramirez J., Torres A. Eur Respir J 2010; 36: 901-906
Overexpression of transforming growth factor-Î²1 in fetal monkey lung results in prenatal pulmonary fibrosis Tarantal A.F., Chen H., Shi T.T., Lu C-H., Fang A.B., Buckley S., Kolb M., Gauldie J., Warburton D., Shi W. Eur Respir J 2010; 36: 907-914
Current data on predictive markers for anti-angiogenic therapy in thoracic tumours Reinmuth N., Thomas M., Meister M., Schnabel P.A., Kreuter M. Eur Respir J 2010; 36: 915-924
Tuberculosis contact investigation in low prevalence countries: a European consensus Erkens C.G.M., Kamphorst M., Abubakar I., Bothamley G.H., Chemtob D., Haas W., Migliori G.B., Rieder H.L., Zellweger J-P., Lange C. Eur Respir J 2010; 36: 925-949
Epigenetic mechanisms and the relationship to childhood asthma Kabesch M., Michel S., Tost J. Eur Respir J 2010; 36: 950-961
Occupational asthma to solder wire containing an adipic acid flux Moore V.C., Burge P.S. Eur Respir J 2010; 36: 962-963
Response to salbutamol in patients with mild asthma treated with nadolol Hanania N.A., Mannava B., Franklin A.E., Lipworth B.J., Williamson P.A., Garner W.J., Dickey B.F., Bond R.A. Eur Respir J 2010; 36: 963-965
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer Malfait T., van Eijkeren M., van Meerbeeck J.P., Tournoy K.G. Eur Respir J 2010; 36: 965-967
Iloprost-induced thrombocytopenia: a case proven by rechallenge Taegtmeyer A.B., Zettler C., Siegemund M., Tsakiris D.A., RÃ¤tz Bravo A.E., Pargger H., Kraehenbuehl S., Haschke M. Eur Respir J 2010; 36: 967-969
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia To K.K.W., Chan K-H., Fung Y-F., Yuen K-Y., Ho P-L. Eur Respir J 2010; 36: 969-971
Assessment of bronchoreversibility in severe emphysema Hansen J.E. Eur Respir J 2010; 36: 972
From the authors: Han M.K., Martinez F.J. Eur Respir J 2010; 36: 973
Inhaled corticosteroids: a controversial add-on treatment in COPD Puhan M.A. Eur Respir J 2010; 36: 973-974
From the authors: Singh S., Loke Y.K. Eur Respir J 2010; 36: 974
From the authors Sin D.D., Man S.F.P. Eur Respir J 2010; 36: 974-975